Scott Hirsch Joins SOLIUS Board of Directors

/in /by

Former CEO of Solta Medical joins SOLIUS Board of Directors

Life Science Partner is pleased to announce the recruitment of SOLIUS’ new Board Member, Scott Hirsch. With a background in leading commercialized medical device companies and business units, Hirsch brings a wealth of regulatory and business strategy experience to SOLIUS. In partnership with Chris Kiple, JD, new CEO of SOLIUS, Hirsch will assist with the fund raising, build out and launch of SOLIUS’ proprietary UVB light therapy technology for treatment of patients with low levels of Vitamin D including a newly developed at-home therapy device.

Hirsch took interest in joining SOLIUS after Valeant’s $250M acquisition of Solta Medical, a former division of Bausch Health Companies that was a leader in the aesthetics industry with a product portfolio that included Thermage®, Fraxel®, Clear + Brilliant®, and VASERlipo® system. His experience with Solta’s direct-to-consumer business model will be critical in building the commercialization and regulatory strategy for SOLIUS.

“With a strong financing background combined with a track record for implementing innovative commercialization plans, Hirsch has the experience and energetic drive to contribute greatly to the Board leadership of SOLIUS,”

Tom Callaway, MD, Founder of Life Science Partner. 

Prior to his CEO role at Solta, Hirsch led a series of Bausch business units including roles such as President, Bausch Foundation, President, Ortho Dermatologics and OraPharma. Earlier in his career, Hirsch was an investor and portfolio manager on Wall Street for Citadel and Vice President for Plural Investments. During his time on the investment side of the business, he also served as the Lead Equity Research Analyst, Specialty Pharmaceuticals and Global Generics at Credit Suisse.

Hirsch earned his Bachelor of Fine Arts from the Rhode Island School of Design and his Master of Business Administration in Finance and Healthcare Management from The Wharton School.

Life Science Partner is also pleased to announce the recruitment of Chris Kiple, JD, former Chief Executive Officer of Ventec Life Systems as Chief Executive Officer of SOLIUS.